— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
Chronic diarrhoea unresponsive to conventional medication: Are you taking lansoprazole?
Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease. Lansoprazole uncommonly causes chronic watery diarrhoea unresponsive to conventional medication as a symptom of collagenous colitis. This association has recently been reported and is not widely known. Correct diagnosis and treatment without this knowledge is impossible. Discontinuation of lansoprazole results in the prompt resolution of diarrhoea.
A 70-year old woman developed watery diarrhoea 4 to 9 times a day. She had interstitial pneumonia at 67 and reflux oesophagitis at 70. Lansoprazole 30 mg/day had been prescribed for reflux oesophagitis for nearly 6 months. Lansoprazole was withdrawn due to its possible side effect of diarrhoea. Colonoscopy disclosed diffuse cloudiness of the mucosa which suggested ulcerative colitis. Consequently sulfasalazine 2 g/day was started. The patient's diarrhoea dramatically disappeared the following day. However, biopsy specimens showed subepithelial collagenous thickening and infiltration of inflammatory cells in the lamina propria confirming the diagnosis of collagenous colitis. One month after sulfasalazine therapy was initiated, both colonoscopic and histological abnormalities resolved completely. Five months later the diarrhoea recurred. The findings on colonoscopy and histology were the same as before confirming a diagnosis of collagenous colitis relapse. The author found that the patient had been taking lansoprazole again three months ahead of the recent episode of diarrhoea. Withdrawal of lansoprazole promptly resolved the diarrhoea. Endoscopic and histological abnormalities were also completely resolved similar to the first episode. Retrospectively, the date of commencement of sulfasalazine and the discontinuation of lansoprazole in the first episode was found to be the same. The author concluded that the patient had lansoprazole-associated collagenous colitis.
This case is reported by Dr Chiba and his colleagues in the Division of Gastroenterology, Nakadori General Hospital, Akita, Japan and it is published on 7 May 2009 in the World Journal of Gastroenterology.
A doctor and a patient can easily recognise the side effects of medication taken recently. However, symptoms occurring in chronic use of a drug such as the present case, diarrhoea 6 months after taking lansoprazole, it might be difficult to suspect this side effect. Therefore, knowledge is important: lansoprazole in chronic use can cause chronic diarrhoea as a symptom of collagenous colitis.
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
Research may lead to improved hearing for some
Novel method of measuring insulin promises improvements in diabetes treatment
Gene variant increases risk of asthma
Secrets of cellular signalling shed light on novel cancer stem cell therapies